/NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES/
David
Rendimonti to assume the role of Chief Executive
Officer
OTTAWA, Oct. 5, 2018 /CNW Telbec/ - LiveWell Canada
Inc. ("LiveWell" or the "Company") (TSXV: LVWL) (OTC:
LXLLF), is pleased to announce that healthcare leader
Mr. David Rendimonti, in addition to his role as President,
will also assume responsibilities as Chief Executive Officer,
effective immediately.
The move is part of LiveWell's vision to become a world leader
in health and wellness through quality outcomes and
strategic partnerships. LiveWell is an innovative Canadian
hemp and cannabis company focused on advanced research on CBD and
other cannabinoids, as well as developing and distributing
prescription and consumer health products supported by
data, discovery, science and technology.
Seann Poli, Co-Founder, Chief
Executive Officer and Director of LiveWell, becomes a Special
Advisor to the Company. In his new role, Mr. Poli will continue his
focus on capital markets efforts including communicating with
dealers, brokers and other market participants. Mr. Poli will
also continue to undertake searching for strategic partnerships and
acquisitions, a community outreach program, coordinating
relationships with various entities including the City of Ottawa, other municipalities, national
and international organizations, and charities.
Tim McCunn, Chairman of LiveWell
Canada, stated, "As a fellow Co-Founder, Seann has been
instrumental in creating an organization with a significant asset
base and strategic partners. He will continue to focus on these
areas and further value-creation opportunities for
LiveWell."
Seann Poli, commented, "David has
a consistent track record of building high performance teams and
top brands that are both best in class and industry. His
performance has been consistently delivered through highly
creative, strategic, tactical and financial plans, as well as
exceptional leadership and flawless execution. We welcome him to an
expanded role with the LiveWell."
Mr. Rendimonti is a healthcare leader with a 30-year track
record of building and leading No. 1 brands, including senior
roles at some of the world's most prominent organizations such as
Johnson & Johnson, Pfizer and Merck. Mr. Rendimonti drove
innovation within the Biotech and Women's Health markets in
Canada and has extensive
experience in global health and wellness markets. His pioneering
spirit, pursuit of innovation and background in capital markets
makes him ideally suited to optimize the Company's growth
trajectory in the fast-developing cannabis and hemp-based health
and wellness markets worldwide.
In his role as President and Chief Executive Officer, Mr.
Rendimonti will continue to focus on executing the Company's global
health and wellness vision, including strategic partnerships,
investments and developing LiveWell's prescription and consumer
health products supported by data, discovery, science
and technology.
About LiveWell Canada:
LiveWell Canada Inc.
(TSXV:LVWL, OTC:LXLLF) is focused on improving health one person at
a time utilizing innovation supported by data, discovery,
science and technology. The cannabis and hemp company is
conducting advanced research on CBD and other cannabinoids, as well
as developing and distributing prescription and consumer health and
wellness products. LiveWell is conducting major research on CBD,
has completed a white paper on CBD from Industrial Hemp, and is
also investing in technologies for the extraction and isolation of
CBD and other cannabinoids for use in prescription and consumer
health products. The Company has secured major supply agreements
for industrial hemp biomass, and has more than 1.5 million
square feet of greenhouse under construction in Ontario and Quebec. It is also supported by business
partners such as Canopy Growth (TSX:WEED, NYSE:CGC) and Canopy
Rivers (TSXV:RIV). For more information, visit
livewellcorp.com.
Cautionary Note Regarding Forward-Looking
Statements
This release includes forward-looking
statements about the Company and its business. Often, but not
always, forward-looking statements can be identified by the use of
words such as "plan", "continue", "expect", "schedule", "project",
"intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or statements
(including negative variations) that certain events or conditions
"may" or "will" occur. Such statements are based on the
current expectations of management. The forward-looking events and
circumstances discussed in this release may not occur by certain
specified dates or at all and could differ materially as a result
of unknown and known risk factors and uncertainties affecting the
Company, including risks regarding the cannabis and hemp industry,
economic factors, the equity markets and risks associated with
growth and competition. The Company cautions that this foregoing
list of material factors is not exhaustive, and readers are
encouraged to read all Risk Factors disclosed in the Company's
Filing Statement dated May 29,
2018.
The forward-looking information contained in this press
release represents expectations of the Company as of the date of
this press release and accordingly, is subject to change after such
date. Readers should not place undue importance on forward-looking
information and should not rely upon this information as of any
other date. While the Company may elect to, it does not undertake
to update this information at any particular time except as
required in accordance with applicable securities laws.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this release.
For more information, visit livewellcorp.com.
SOURCE LiveWell Canada Inc.